Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 12:29 pm Sale | 2023-12-31 | 13G | VECTIVBIO HLDG AG VECT | Eventide Asset Management, LLC | 0 0.000% | -3,405,644![]() (Position Closed) | Filing History |
| 2024-02-14 12:21 pm Sale | 2023-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Eventide Asset Management, LLC | 0 0.000% | -234,537![]() (Position Closed) | Filing History |
| 2024-02-14 12:18 pm Purchase | 2023-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Eventide Asset Management, LLC | 4,529,997 8.300% | 1,379,997![]() (+43.81%) | Filing History |
| 2024-02-14 12:15 pm Sale | 2023-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Eventide Asset Management, LLC | 0 0.000% | -394,718![]() (Position Closed) | Filing History |
| 2024-02-14 12:04 pm Purchase | 2023-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Eventide Asset Management, LLC | 2,630,478 8.070% | 885![]() (+0.03%) | Filing History |
| 2024-02-14 12:02 pm Sale | 2023-12-31 | 13G | 908 DEVICES INC MASS | Eventide Asset Management, LLC | 1,430,995 4.420% | -799,670![]() (-35.85%) | Filing History |
| 2024-02-14 11:59 am Purchase | 2023-12-31 | 13G | KORRO BIO INC KRRO | Eventide Asset Management, LLC | 546,325 6.830% | 546,325![]() (New Position) | Filing History |
| 2024-02-14 11:54 am Purchase | 2023-12-31 | 13G | INOZYME PHARMA INC INZY | Eventide Asset Management, LLC | 3,179,837 5.150% | 3,179,837![]() (New Position) | Filing History |
| 2024-02-14 11:48 am Purchase | 2023-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Eventide Asset Management, LLC | 3,630,013 6.640% | 3,630,013![]() (New Position) | Filing History |
| 2023-12-11 5:15 pm Purchase | 2023-11-30 | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Eventide Asset Management, LLC | 11,559,975 16.340% | 3,745,936![]() (+47.94%) | Filing History |
| 2023-12-11 5:14 pm Purchase | 2023-11-30 | 13G | AURA BIOSCIENCES INC AURA | Eventide Asset Management, LLC | 5,802,682 11.820% | 3,551,314![]() (+157.74%) | Filing History |
| 2023-12-11 5:13 pm Purchase | 2023-11-30 | 13G | LEXEO THERAPEUTICS INC LXEO | Eventide Asset Management, LLC | 3,002,831 11.930% | 3,002,831![]() (New Position) | Filing History |
| 2023-11-13 4:10 pm Purchase | 2023-11-01 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Eventide Asset Management, LLC | 1,394,336 9.990% | 1,394,336![]() (New Position) | Filing History |
| 2023-11-13 2:43 pm Purchase | 2023-10-31 | 13G | XOMETRY, INC. CLASS A XMTR | Eventide Asset Management, LLC | 5,730,339 12.650% | 5,730,339![]() (New Position) | Filing History |
| 2023-10-10 3:40 pm Purchase | 2023-09-30 | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Eventide Asset Management, LLC | 7,814,039 11.070% | 7,814,039![]() (New Position) | Filing History |
| 2023-02-14 3:04 pm Sale | 2022-12-31 | 13G | VITAL FARMS INC VITL | Eventide Asset Management, LLC | 0 0.000% | -2,950,000![]() (Position Closed) | Filing History |
| 2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Eventide Asset Management, LLC | 0 0.000% | -270,898![]() (Position Closed) | Filing History |
| 2023-02-14 2:50 pm Sale | 2022-12-31 | 13G | ESSA PHARMA INC EPIX | Eventide Asset Management, LLC | 0 0.000% | -3,318,647![]() (Position Closed) | Filing History |
| 2023-02-14 2:37 pm Sale | 2022-12-31 | 13G | ZYMEWORKS INC ZYME | Eventide Asset Management, LLC | 0 0.000% | -2,819,135![]() (Position Closed) | Filing History |
| 2023-02-14 2:06 pm Purchase | 2022-12-31 | 13G | VECTIVBIO HLDG AG VECT | Eventide Asset Management, LLC | 3,405,644 5.400% | 1,066,600![]() (+45.60%) | Filing History |

